📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

Hemodialysis

46.3 mL/min

Moderately Dialyzable

Some removal expected. Half-life: 43.6 hours. Monitor drug levels.

Data Used:
✅ protein_binding, molar_mass, mw_factor, half_life
⚠️ Missing: vd

Free fraction: 0.21 Mw factor: 0.85 Vd factor: 0.8 Hl factor: 1.2 Half life: 43.6 hours Half life category: Very Long (24-72h)

🫀

Peritoneal Dialysis

1.2 mL/min

Low PD Clearance

Minimal removal expected. No supplementation needed. Half-life: 43.6 hours.

Data Used:
✅ protein_binding, molar_mass, half_life

Free fraction: 0.21 Half life: 43.6 hours Half life category: Very Long (24-72h)

🔄

Plasmapheresis (TPE)

Unable to Assess

Insufficient data for TPE risk assessment. Protein binding and Vd required.

Data Used:
✅ protein_binding, half_life
⚠️ Missing: vd

Half life: 43.6 hours Half life category: Very Long (24-72h)

🧪

Hemoadsorption

Cannot Assess

Vd data required for hemoadsorption effectiveness assessment.

Data Used:
✅ half_life
⚠️ Missing: vd

Half life: 43.6 hours Half life category: Very Long (24-72h)

📋 Summary of Estimates

Modality	Clearance/Value	Half-Life	Classification	Data Quality
Hemodialysis	46.3 mL/min	43.6 hours	Moderately Dialyzable	Partial Data
Peritoneal Dialysis	1.2 mL/min	43.6 hours	Low PD Clearance	Complete Data
Plasmapheresis (TPE)	Unable to Assess	43.6 hours	N/A	Partial Data
Hemoadsorption	Cannot Assess	43.6 hours	N/A	Partial Data

📌 Important Notes

Hemodialysis: Estimates based on high-flux dialyzer (urea clearance 270 mL/min), Qb 300 mL/min, 4-hour session.
Peritoneal Dialysis: Estimates based on CAPD (Continuous Ambulatory Peritoneal Dialysis).
TPE: Risk assessment based on protein binding and volume of distribution.
Hemoadsorption: Effectiveness based on volume of distribution. Most effective for drugs with Vd < 0.2 L/kg.
Data Quality: Estimates with missing data use default assumptions. Consider adding missing data for more accurate predictions.
Clinical Note: These are descriptive estimates only. Always consult clinical guidelines and monitor drug levels when available.